Harold E. Selick
13Patents
12h-index
20Co-inventors
74Inventor score
Filing activity: Dec 19, 1990 → Apr 7, 2008
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5585089A | Humanized immunoglobulins | Chemistry; Metallurgy | 2,723 | Expired |
| US5530101A | Humanized immunoglobulins | Chemistry; Metallurgy | 2,162 | Expired |
| US5693762A | Humanized immunoglobulins | Chemistry; Metallurgy | 1,935 | Expired |
| US6180370A | Humanized immunoglobulins and methods of making the same | Chemistry; Metallurgy | 1,379 | Expired |
| US5693761A | Polynucleotides encoding improved humanized immunoglobulins | Chemistry; Metallurgy | 1,188 | Expired |
| US5607691A | Compositions and methods for enhanced drug delivery | Human Necessities | 255 | Expired |
| US7022500B1 | Humanized immunoglobulins | Chemistry; Metallurgy | 92 | Expired |
| US6168914A | System and method for solid-phase parallel synthesis of a combinatorial collection of compounds | Emerging Cross-Sectional Technologies | 76 | Expired |
| US6083682A | System and method for solid-phase parallel synthesis of a combinatorial collection of compounds | Emerging Cross-Sectional Technologies | 58 | Expired |
| US5962250A | Split multi-well plate and methods | Emerging Cross-Sectional Technologies | 56 | Expired |
| US6043027A | Multi-well single-membrane permeation device and methods | Emerging Cross-Sectional Technologies | 35 | Expired |
| US5814603A | Compounds with PTH activity | Chemistry; Metallurgy | 33 | Expired |
| US8765690B2 | Treatment of cancer with glufosfamide in patients not receiving insulin therapy | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.